The fintech firm Nukkleus said on Thursday that it has regained compliance with the market value of listed securities requirement as outlined in Nasdaq Listing Rules and the market value of publicly held shares requirement as outlined in the rules.
As a result, Nasdaq has officially canceled the hearing scheduled for January 21, 2025, confirming that Nukkleus's securities will continue to be listed and traded on The Nasdaq Stock Market.
Nukkleus shares jumped 90% in premarket trading Friday.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。